These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 2334132

  • 21. Acetylation pharmacogenetics: experimental models for human toxicity.
    Weber WW.
    Fed Proc; 1984 May 15; 43(8):2332-7. PubMed ID: 6714442
    [Abstract] [Full Text] [Related]

  • 22. [Determination of the N-acetyltransferase phenotype in urothelial cancer patients and healthy controls].
    Sone M.
    Hinyokika Kiyo; 1986 Aug 15; 32(8):1085-92. PubMed ID: 3788733
    [Abstract] [Full Text] [Related]

  • 23. N-acetylation phenotype and genotype and risk of bladder cancer in benzidine-exposed workers.
    Hayes RB, Bi W, Rothman N, Broly F, Caporaso N, Feng P, You X, Yin S, Woosley RL, Meyer UA.
    Carcinogenesis; 1993 Apr 15; 14(4):675-8. PubMed ID: 8472331
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo.
    Andres HH, Weber WW.
    Drug Metab Dispos; 1986 Apr 15; 14(4):382-5. PubMed ID: 2873982
    [Abstract] [Full Text] [Related]

  • 28. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster.
    Hein DW, Omichinski JG, Brewer JA, Weber WW.
    J Pharmacol Exp Ther; 1982 Jan 15; 220(1):8-15. PubMed ID: 7053425
    [Abstract] [Full Text] [Related]

  • 29. Overrepresentation of the slow acetylator phenotype in painters suffering from urinary bladder cancer.
    Golka K, Kempkes M, Flieger A, Blaszkewicz M, Bolt HM.
    Med Lav; 1997 Jan 15; 88(5):425-6. PubMed ID: 9489306
    [No Abstract] [Full Text] [Related]

  • 30. [Distribution of acetylator phenotypes in the normal Moscow city population and in chronic alcoholism].
    Lil'in ET, Korsunskaia MP, Meksin VA, Drozdov ES, Nazarov VV.
    Genetika; 1984 Sep 15; 20(9):1557-9. PubMed ID: 6542045
    [Abstract] [Full Text] [Related]

  • 31. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
    Ylitalo P, Auterinen L, Marttinen A, Koivula T.
    Int J Clin Pharmacol Res; 1984 Sep 15; 4(2):141-4. PubMed ID: 6469440
    [Abstract] [Full Text] [Related]

  • 32. Arylamine N-acetyltransferase activity of the human placenta.
    Derewlany LO, Knie B, Koren G.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):756-60. PubMed ID: 8182542
    [Abstract] [Full Text] [Related]

  • 33. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines.
    Wolf H, Lower GM, Bryan GT.
    Scand J Urol Nephrol; 1980 May 15; 14(2):161-5. PubMed ID: 7209420
    [Abstract] [Full Text] [Related]

  • 34. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
    Skretowicz J, Polakowski P, Jeromin L, Zasada M, Szymańska J, Krajewska B.
    Med Pr; 1988 May 15; 39(4):241-5. PubMed ID: 3237058
    [Abstract] [Full Text] [Related]

  • 35. Acetylation phenotype is not associated with breast cancer.
    Ilett KF, Detchon P, Ingram DM, Castleden WM.
    Cancer Res; 1990 Oct 15; 50(20):6649-51. PubMed ID: 2208127
    [Abstract] [Full Text] [Related]

  • 36. Acetylator polymorphism in Alzheimer's disease.
    Ladero JM, Barquero MS, Coria F, Molina JA, Jiménez-Jiménez FJ, Benítez J.
    Eur J Med; 1993 May 15; 2(5):281-3. PubMed ID: 8252158
    [Abstract] [Full Text] [Related]

  • 37. Inheritance of acetylator phenotype in mice.
    Tannen RH, Weber WW.
    J Pharmacol Exp Ther; 1980 Jun 15; 213(3):480-4. PubMed ID: 6970808
    [Abstract] [Full Text] [Related]

  • 38. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM, Bell DA, Watson MA, Skipper PL, Tannenbaum SR, Chan KK, Ross RK, Yu MC.
    Cancer Epidemiol Biomarkers Prev; 2000 Jun 15; 9(6):619-23. PubMed ID: 10868698
    [Abstract] [Full Text] [Related]

  • 39. Acetylation.
    Weber WW.
    Birth Defects Orig Artic Ser; 1990 Jun 15; 26(1):43-65. PubMed ID: 2224079
    [Abstract] [Full Text] [Related]

  • 40. The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: a review considering ethnic differences.
    Golka K, Prior V, Blaszkewicz M, Bolt HM.
    Toxicol Lett; 2002 Mar 10; 128(1-3):229-41. PubMed ID: 11869833
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.